SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-022594
Filing Date
2023-06-27
Accepted
2023-06-27 14:00:14
Documents
14
Period of Report
2023-06-27
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 41374
2 ex99-1.htm EX-99.1 16411
3 ex99-1_001.jpg GRAPHIC 4506
  Complete submission text file 0001493152-23-022594.txt   244475

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE aim-20230627.xsd EX-101.SCH 3015
5 XBRL LABEL FILE aim-20230627_lab.xml EX-101.LAB 34916
6 XBRL PRESENTATION FILE aim-20230627_pre.xml EX-101.PRE 22790
8 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3365
Mailing Address 2117 SW HIGHWAY 484 OCALA FL 32801
Business Address 2117 SW HIGHWAY 484 OCALA FL 32801 352-448-7797
AIM ImmunoTech Inc. (Filer) CIK: 0000946644 (see all company filings)

IRS No.: 520845822 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-27072 | Film No.: 231046153
SIC: 2836 Biological Products, (No Diagnostic Substances)